Women diagnosed with breast cancer prior to age 45 years (<45y) and within the first 5 years postpartum (postpartum breast cancer, PPBC) have the greatest risk for distal metastatic recurrence. Pooling data from the Colorado Young Women Breast Cancer cohort and the Breast Cancer Health Disparities Study (N=2519 cases), we examined the association of parity, age, and clinical factors with overall survival (OS) of breast cancer over 15 years of follow-up. Women with PPBC diagnosed at <45y had the lowest OS (p<0.0001), while OS of nulliparous cases diagnosed at <45y did not differ from OS of cases diagnosed 45–65y regardless of parity status. After adjustment for study site, race/ethnicity, clinical stage, year of diagnosis, and stratification for estrogen receptor status, PPBC remained an independent factor associated with poor OS. Among cases diagnosed at <45y, nulliparous cases had 1.6 times better OS (hazard ratio (HR)=0.61, 95%CI 0.42–0.87) compared to those with PPBC, with a more pronounced survival difference among stage I breast cancers (HR=0.30, 95%CI 0.11–0.79). Among very young women diagnosed at age ≤35y, nulliparous cases had 2.3 times better OS (HR=0.44, 95%CI 0.23–0.84) compared to PPBC. Our results suggest that postpartum status is the main driver of poor prognosis in young women with breast cancer, with the strongest association in patients diagnosed at age ≤35y and in those with stage I disease.
26 April 2016 in Breast Cancer Research and Treatment
Traditional phase III clinical trials are powered to detect an overall treatment effect. However, it has increasingly been shown that many treatments are effective only for a subset of a population. The adaptive signature design uses genomic/proteomic information to prospectively predict a subset of patients more sensitive to treatment. Tests for overall treatment effect and for treatment effect in the predicted subset are conducted. In this work properties of the adaptive signature design are investigated through simulation. It was found that models which excluded expression main effect terms had higher empirical power than models which included them.
1 September 2001 in Journal of the American Dietetic Association